You are here

CAR-T

CAR-T therapy makes early inroads in treating brain cancer

Stat

Wed, 12/28/16 - 07:35 pm

Juno Therapeutics Defeats Kite Pharma’s Challenge to CAR T-Cell Patent

Yahoo

Mon, 12/19/16 - 11:41 am

Juno Therapeutics

Novartis' Big News at ASH? It's Still in the CAR-T Race

Motley Fool

Fri, 12/16/16 - 11:28 am

Kite, Juno Cancer Data Fuel Price Dip

Investopedia

Thu, 12/8/16 - 10:05 am

Juno Therapeutics

non-Hodgkins lymphoma

Novartis Makes Its Case For Driving A CAR Into The Real World

Seeking Alpha

Mon, 12/5/16 - 10:43 pm

Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission

Endpoints

Mon, 12/5/16 - 10:01 am

clinical trials

acute lymphoblastic leukemia

In wake of a CAR-T restructuring, Novartis says it’s ready to hunt a pioneering OK for lead program

Endpoints

Sun, 12/4/16 - 12:24 pm

B-cell acute lymphoblastic leukemia

Juno and the FDA screwed up. People died. What now?

Endpoints

Mon, 11/28/16 - 09:47 am

Juno Therapeutics

clinical trials

Latest deaths in Juno trial underscore the need for greater transparency in clinical trials

Stat

Fri, 11/25/16 - 09:15 am

clinical trials

Juno Therapeutics

Juno Therapeutics plummets 30% in pre-market trade after two patient deaths

Marketwatch

Wed, 11/23/16 - 10:20 am

Juno Therapeutics

clinical trials

Kite Pharma to keep anticipated CAR-T launch 'controlled' and targeted at certain hospitals

Medical Marketing and Media

Wed, 11/16/16 - 09:59 am

diffuse large B-cell lymphoma

Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be

Endpoints

Tue, 10/25/16 - 10:10 am

acute lymphoblastic leukemia

diffuse large B-cell lymphoma

Kite Pharma Details KTE-C19 Launch Preparedness and Near-Term, Next Generation CAR/TCR Product Candidates at Investor Day

Yahoo

Thu, 10/20/16 - 09:17 am

non-Hodgkin's lymphoma

7 Reasons Celgene Is the Best Bet in Biotech

Motley Fool

Tue, 10/18/16 - 09:25 am

Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook

Yahoo/Benzinga

Sat, 10/8/16 - 03:46 pm

clinical trials

refractory lymphoma

Kite Pharma Claims CAR-T Trial Victory, FDA Filing Next

TheStreet.com

Tue, 09/27/16 - 09:56 am

diffuse large B-cell lymphoma

Stung by patient deaths, a small Juno study points to a Goldilocks formula for CAR-T

Endpoints

Thu, 09/8/16 - 09:10 am

Juno Therapeutics

Novartis’ CAR-T chief Azam is leaving, but pharma giant denies any ‘retreat’ is underway

Endpoints

Sat, 09/3/16 - 12:06 pm

Could Toxicity Issues Topple CAR-T Cancer Therapies?

Motley Fool

Sun, 08/28/16 - 10:09 am

clinical trials

Juno Therapeutics

Ziopharma Oncology

Controversial patient deaths in CAR-T study spur a class action suit against Juno

Endpoints

Wed, 08/17/16 - 12:10 pm

Juno Therapeutics

Pages